Novonesis (Novozymes) B (NZYM)
Market Closed
12 Jun, 15:30
€
51. 72
-0.04
-0.0773%
€
24.93B Market Cap
59.14 P/E Ratio
3.42% Div Yield
12 Volume
0 Eps
€ 51.76
Previous Close Want to track NZYM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Novonesis (Novozymes) B (NZYM) Statistics
Valuation metrics
Market Cap 24.93B
Enterprise value 26.02B
Trailing P/E (ttm) 40.66
Forward P/E -
PEG ratio -
Price/Sales (ttm) 5.7
Price/Book (mrq) 2.18
Enterprise Value/Revenue 6.26
Enterprise Value/EBITDA 16.93
Overview
Shares outstanding 465.91M
Float 346.63M
Shares short -
% Held by insiders 0.16%
% Held by institutions 0.4%
Average volume (10 days) 10
Average volume (90 days) 3
Price summary
52-Week low 45.31
52-Week high 65.48
Beta 0.75
50-Day moving average 50.68
200-Day moving average 54.35
Dividends and splits
Forward annual dividend rate 1.14
Forward annual dividend yield 0.0221%
Trailing annual dividend rate 0.87
Trailing annual dividend yield 0.0169%
5-Year annual dividend yield 1.48%
Payout ratio 0.69
Dividend Date 31 Mar 2026
Ex-Dividend Date 24 Mar 2026
Last split factor 5:1
Last split Date 28 Nov 2011
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.14%
Operating margin 0.2%
Operational effectiveness
Return on assets 0.04%
Return on equity 0.05%
Income Statement
Revenue (ttm) 4.16B
Revenue per share (ttm) 8.9
Quarterly revenue growth (yoy) 0.01%
Gross profit (ttm) 2.31B
EBITDA 905.2M
Net income to common (ttm) 583.6M
Diluted EPS (ttm) 1.25
Quarterly earnings growth (yoy) 0.42%
Balance Sheet
Total cash (mrq) 275.3M
Total cash per share (mrq) 0.59
Total debt (mrq) 3.01B
Total Debt/Equity (mrq) 27.69
Current ratio (mrq) 0.72%
Book value per share (mrq) 23.3
Cash Flow
Cash flow statement 1.22B
Levered free cash flow (LFCF) 771.77M
